Correlation Between Apogee Therapeutics, and Hybrid Kinetic

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Hybrid Kinetic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Hybrid Kinetic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and Hybrid Kinetic Group, you can compare the effects of market volatilities on Apogee Therapeutics, and Hybrid Kinetic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Hybrid Kinetic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Hybrid Kinetic.

Diversification Opportunities for Apogee Therapeutics, and Hybrid Kinetic

0.0

Correlation Coefficient

Apogee Therapeutics,  Hybrid Kinetic

Pay attention - limited upside

The 3 months correlation between Apogee and Hybrid is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Hybrid Kinetic Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hybrid Kinetic Group and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Hybrid Kinetic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hybrid Kinetic Group has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Hybrid Kinetic go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Hybrid Kinetic

If you would invest  0.50  in Hybrid Kinetic Group on October 23, 2024 and sell it today you would earn a total of  0.00  from holding Hybrid Kinetic Group or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.36%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  Hybrid Kinetic Group

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Hybrid Kinetic Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hybrid Kinetic Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Hybrid Kinetic is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Apogee Therapeutics, and Hybrid Kinetic

The main advantage of trading using opposite Apogee Therapeutics, and Hybrid Kinetic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Hybrid Kinetic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hybrid Kinetic will offset losses from the drop in Hybrid Kinetic's long position.

The idea behind Apogee Therapeutics, Common and Hybrid Kinetic Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.